Collaborative Research Development Grant – Microsoft AI for Health

The Collaborative Research Development Grant – Microsoft AI for Health supports innovative research in ovarian and related gynecologic cancers using AI and machine learning. With up to $900,000 in funding over three years, this opportunity encourages interdisciplinary collaborations and requires a partnership with Microsoft. Eligible applicants include full-time faculty and researchers with a focus on high-impact research. This initiative aims to enhance screening, detection, and treatment through advanced technology and collaboration.

Collaborative Research Development Grant – Microsoft AI for Health
The purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects using AI or machine learning that may involve several investigators within one institution or collaborations between groups in multiple institutions.
Funding
Support of up to $300,000 USD annually for three years ($900,000 USD total) will be granted to the institution of the Principal Investigator.
For this opportunity, OCRA is partnering with Microsoft AI for Health, a philanthropic program at Microsoft, which offers access to advanced Microsoft Azure cloud computing and collaboration with data science experts for nonprofits, academia, and researchers working on challenges in the area of health, including ovarian cancer. Investigators funded through this grant opportunity have access to support from Microsoft in the form of Azure computing credits, and in-kind data science support. This in-kind support from Microsoft will be in addition to the financial support from OCRA.

Eligibility

The Principal Investigator (one Principal Investigator must be selected) and other investigators must have full-time faculty appointments in a school of medicine or public health or recognized non-profit scientific research facility. At least one key investigator must be a physician with expertise on ovarian cancer.International collaborations are welcome.The selection committee will consider most favorably applications that are creative, original, that leverage AI/machine learning, and that hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics.Submissions that focus on health services research, quality of life, and epidemiology are also encouraged. Proposed projects should focus on ovarian cancers and/or related gynecologic cancers.The primary review criteria will be the likelihood that the investigators can leverage this funding to establish a research team capable of performing high-impact research and competing successfully for additional funding, and leverage the resources provided through Microsoft AI for Health.International applicants are welcome to apply.The CRDG-AI grant requires a partnership with Microsoft. If your grant does not have an AI component or you do not wish to partner with Microsoft AI for Health, you should apply for the Collaborative Research Development Grant.Each applicant may submit only one LOI per grant cycle.Additionally, grant recipients can only have one OCRA grant active at a time, if the grant recipient already has an active OCRA grant, the current grant must end before the CRDG may begin.Educational and not-for-profit organizations from anywhere in the world are welcome to apply for OCRA grants.

Ineligibility

Principal Investigator should not currently be in a training program.At this time, OCRA does not fund for-profit entities.Tuition and fees are not an allowable cost on OCRA grants.